MedPath

Efficacy of Hridayarnava Rasa on hyperlipidemia

Phase 1
Completed
Conditions
Health Condition 1: null- Hyperlipidemia
Registration Number
CTRI/2015/08/006127
Lead Sponsor
Institute for Post Graduate Teaching and Research in Ayurveda
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
60
Inclusion Criteria

Age between 20 to 60 years

Elevated levels of S. Cholesterol ( >200mg/dL) and/or

Elevated S. Triglycerides ( >150mg/dL) and/or

Elevated S.LDL ( >130mg/dL) and/or

Elevated S. VLDL ( >40mg/dL)

Exclusion Criteria

Age less than 20 years and more than 60 years.

Any concomitant serious disorders of liver, kidneys, heart, lung and other organs.

Gravid women and lactating mothers.

Persons undergoing treatment for any other serious illness.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
It is expected that the trial drugs will exert a significant action over lipids of different categories (cholesterol, triglyceride, LDL, VLDL, HDL)Timepoint: up to 8 weeks
Secondary Outcome Measures
NameTimeMethod
By maintaining the healthy level of lipids, the drug will control conditions associated with hyperlipidemia like various cardiovascular diseases such as Atherosclerosis, Cardiac Arrest, Stroke, Heart Attack, etc.Timepoint: up to 8 weeks
© Copyright 2025. All Rights Reserved by MedPath